Vivos therapeutics schedules release of third quarter 2024 financial results and conference call

Littleton, colo., nov. 13, 2024 (globe newswire) -- vivos therapeutics, inc. (“vivos” or the “company”) (nasdaq: vvos), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders (including all severities of obstructive sleep apnea (osa) in adults), today announced it plans to release its third quarter 2024 financial results after market close on thursday, november 14, 2024.
VVOS Ratings Summary
VVOS Quant Ranking